Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lensar (LNSR) Cash & Equivalents (2019 - 2025)

Historic Cash & Equivalents for Lensar (LNSR) over the last 7 years, with Q3 2025 value amounting to $12.8 million.

  • Lensar's Cash & Equivalents rose 2216.05% to $12.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.8 million, marking a year-over-year increase of 2216.05%. This contributed to the annual value of $16.3 million for FY2024, which is 2113.38% down from last year.
  • Latest data reveals that Lensar reported Cash & Equivalents of $12.8 million as of Q3 2025, which was up 2216.05% from $15.1 million recorded in Q2 2025.
  • Lensar's 5-year Cash & Equivalents high stood at $35.9 million for Q1 2021, and its period low was $10.4 million during Q3 2024.
  • Over the past 5 years, Lensar's median Cash & Equivalents value was $20.1 million (recorded in 2023), while the average stood at $21.9 million.
  • As far as peak fluctuations go, Lensar's Cash & Equivalents skyrocketed by 4052.75% in 2023, and later tumbled by 5809.79% in 2024.
  • Quarter analysis of 5 years shows Lensar's Cash & Equivalents stood at $31.6 million in 2021, then plummeted by 53.62% to $14.7 million in 2022, then surged by 40.53% to $20.6 million in 2023, then fell by 21.13% to $16.3 million in 2024, then fell by 21.56% to $12.8 million in 2025.
  • Its Cash & Equivalents stands at $12.8 million for Q3 2025, versus $15.1 million for Q2 2025 and $19.5 million for Q1 2025.